The data showed that the mRNA expression levels of CD68, CD163 and SIGLEC15 were higher in tumor tissues than in normal tissues (Figure 1A; Supplementary Figure 1A) across a broad spectrum of human cancers, including glioma. This evidence concerns the gene CD163 and cancer.